Business
Opterion Health AG Appoints Industry Leaders Rice Powell and Mark Hahn to Board of Directors
MUTTENZ, Switzerland, June 23, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a Swiss-based life sciences company developing a next-generation, non-glucose based peritoneal dialysis (PD) solution, today announced the appointment of two highly accomplished executives to its Board of Directors: Rice Powell, former Chairman and CEO of Fresenius Medical Care, and Mark Hahn, Chief Financial Officer of Verona Pharma and a veteran biotech finance leader. These appointments represent a significant step fo
About this update from Fresenius Medical Care Ag
[{"type":"image","alt":"Opterion Health AG","displaySize":"","headline":null,"caption":"Opterion Health AG","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":106,"url":"https://media.zenfs.com/en/globenewswire.com/8d337ae1fab32870c9f53cc33075717e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2qavAkwxpNP.mOp2PCntrA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0ODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8d337ae1fab32870c9f53cc33075717e","width":300,"height":106}},"lazy":false},{"type":"text","content":"MUTTENZ, Switzerland, June 23, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a Swiss-based life sciences company developing a next-generation, non-glucose based peritoneal dialysis (PD) solution, today announced the appointment of two highly accomplished executives to its Board of Directors: Rice Powell, former Chairman and CEO of Fresenius Medical Care, and Mark Hahn, Chief Financial Officer of Verona Pharma and a veteran biotech finance leader.","length":449,"tagName":"p"},{"type":"text","content":"These appointments represent a significant step forward in the strategic development of Opterion Health as it prepares for clinical trials and future commercialization. Rice Powell and Mark Hahn have demonstrated decades of leadership in renal care, biotechnology, and corporate strategy, reinforcing the company’s commitment to innovation and improving patient outcomes.","length":371,"tagName":"p"},{"type":"text","content":"Rice Powell brings more than 30 years of experience in the global dialysis and healthcare industry. As Chairman and CEO of Fresenius Medical Care, he led the world’s largest provider of dialysis products and services through a decade of strategic transformation and international growth. His leadership was instrumental in expanding access to renal therapies and improving standards of care across continents.","length":409,"tagName":"p"},{"type":"image","alt":"Rice_Powell_image","displaySize":"","headline":null,"caption":"Rice_Powell_image","className":"","disableSlideshowImg":false,"size":{"original":{"width":1652,"height":1400,"url":"https://media.zenfs.com/en/globenewswire.com/2cb4b8ae6c6d6fbcfd04559410472c34"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KPr_17FacDCJUeUbPmmMpw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTgxNDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/2cb4b8ae6c6d6fbcfd...